Disclosures for "Defining Progression Independent of Relapse Activity in Early Multiple Sclerosis"
-
Mr. Ayaz has nothing to disclose.
-
Ahmed Serkan Emekli has nothing to disclose.
-
The institution of Dr. Gunduz has received personal compensation in the range of $0-$499 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis Pharmaceuticals. Dr. Gunduz has received research support from Turkish Neuroimmunology Society.
-
Dr. Kurtuncu has nothing to disclose.